Fukuda A I, Breuel K F
Department of Obstetrics and Gynecology, James H. Quillen College of Medicine, College of Medicine, East Tennessee State, Johnson City 37614-0569, USA.
Hum Reprod. 1996 Dec;11(12):2746-9. doi: 10.1093/oxfordjournals.humrep.a019202.
Platelet activating factor (PAF) was administered to female mice in order to investigate its effect on ovulation rate and on oocyte quality including their in-vitro embryonic development, implantation and uterine receptivity. In experiment 1, 4-week-old female mice were assigned to receive PAF or phosphate buffered saline for 4 consecutive days. On the second day of this treatment, pregnant mares' serum gonadotrophin was administered and human chorionic gonadotrophin (HCG) 48 h later, after which copulation occurred. Oocytes were collected on the following day and evaluated. The mean number of oocytes and zygotes (two pronuclear stage embryos) recovered from the PAF-treated group was not different from the control group (31 versus 27), but the proportion of zygotes was higher in PAF-treated group than in controls (83 versus 68%, P < 0.05, PAF versus controls). Although the rate of in-vitro first cleavage was not different in the two groups (82 versus 69% respectively), hatching was higher in the PAF-treated group than control mice (99 versus 83%, P < 0.01). In experiment 2, the in-vitro developed blastocysts from experiment 1 were transferred into the uterus of day 3 pseudopregnant PAF-treated or control recipients. Three different combinations of intrauterine transfer were performed; PAF embryo to control recipient (PAF-->C: n = 19), control embryo to PAF recipient (C-->PAF: n = 19), and control embryo to control recipient (C-->C: n = 22). Implantation and abortion were assessed on day 19 posttransfer. The implantation rate of C-->PAF (23.7%) was lower than C-->C (31.1%, P < 0.05), but was not different from PAF-->C (31.2%). Further, C-->PAF showed a higher abortion rate per embryo (29.6%) than PAF-->C (12.7%, P < 0.05), but was not different from C-->C (24.4%). In the present study, PAF administration enables females to produce oocytes with a higher potential for fertilization, in-vitro development and implantation, but has a detrimental effect on uterine receptivity to embryos.
为了研究血小板活化因子(PAF)对排卵率以及卵母细胞质量(包括其体外胚胎发育、着床和子宫容受性)的影响,将PAF注射到雌性小鼠体内。在实验1中,将4周龄的雌性小鼠分为两组,连续4天分别给予PAF或磷酸盐缓冲盐水。在治疗的第二天,注射孕马血清促性腺激素,48小时后注射人绒毛膜促性腺激素(HCG),之后安排小鼠交配。次日收集卵母细胞并进行评估。从PAF处理组回收的卵母细胞和受精卵(双原核期胚胎)的平均数量与对照组无差异(分别为31个和27个),但PAF处理组的受精卵比例高于对照组(分别为83%和68%,PAF组与对照组相比,P<0.05)。虽然两组的体外首次卵裂率无差异(分别为82%和69%),但PAF处理组的孵化率高于对照小鼠(分别为99%和83%,P<0.01)。在实验2中,将实验1中体外发育的囊胚移植到第3天经PAF处理或对照的假孕受体子宫内。进行了三种不同的子宫内移植组合;PAF胚胎移植到对照受体(PAF→C:n = 19)、对照胚胎移植到PAF受体(C→PAF:n = 19)以及对照胚胎移植到对照受体(C→C:n = 22)。在移植后第19天评估着床和流产情况。C→PAF的着床率(23.7%)低于C→C(31.1%,P<0.05),但与PAF→C(31.2%)无差异。此外,C→PAF每胚胎的流产率(29.6%)高于PAF→C(12.7%,P<0.05),但与C→C(24.4%)无差异。在本研究中,给予PAF可使雌性产生具有更高受精、体外发育和着床潜力的卵母细胞,但对子宫对胚胎的容受性有不利影响。